SALINAS, Calif.–Next Pharmaceuticals promoted Deanne Dolnick, a five-year sales executive with the company, to vice president. In her new role, she will lead operations and sales for Next Pharmaceuticals.

Dolnick, an 11-year veteran of the natural products industry, has held various leadership positions in sales, training and product management and has a master’s of science degree in dietetics from California State University, Northridge. During her tenure at Next, Dolnick most recently directed the process for getting the company up to cGMP regulations as required by FDA, which included overseeing quality assurance, quality control, operations and personnel training. In her role as sales director, Dolnick drove significant increases in revenue and boosted sales significantly during the height of the economic recession from 2008 to 2009.

“Deanne has been instrumental in helping Next Pharmaceuticals evolve into a company that not only provides top-quality health supplements that are sold across the world, but also conforms to the highest consumer and regulatory standards,” said Next Pharmaceuticals CEO Charles Kosmont. “Her expertise and dedication have contributed to the company’s growth and development, and I’m certain that she’ll accomplish even more in her new leadership role.”

Founded in1997, Next Pharmaceuticals provides patented, science-based natural ingredients for healthy living products in the dietary supplement, food and beverage industries. Next Pharmaceuticals has developed six patented and proprietary plant extracts as well as Chromulin®, a form of the essential trace mineral chromium. Next Pharmaceuticals’ proprietary formulations include  Relora® for stress, stress-related eating and weight management; Seditol® for improved, more restful sleep; Nexrutine® for inflammation due to over exertion and exercise; Citri-Z® for heart health; Flavoxine® for balanced cholesterol levels; and Citrofen® for joint mobility and comfort.